Novartis Patient Assistance Foundation

NPAF is an independent, 501(c)(3) non-profit, non-commercial entity. Patients who cannot afford the cost of their Novartis medication may be eligible to receive them from NPAF at no cost.

To be eligible, patients must:

Reside in the United States or a U.S. Territory
Be treated by a licensed U.S. healthcare provider on an outpatient basis
Meet income and affordability guidelines*

How it works:

Patients are enrolled for up to 12 months
Annual re-enrollment is required
Enrolled patients get Novartis medication at no cost

*See below for more information about eligibility. Criteria vary by product.

Select your medication(s) from the list below, review the product-specific requirements for each medication(s), and follow the directions provided to apply.

Adakveo® (crizanlizumab-tmca)

Income Limits
To be eligible, you must meet the income guidelines, which may vary by product and household size.
Please click on the link to see if you may qualify. Check eligibility (PDF 0.3 MB)

Application Instructions
For New Patients: Apply online through the Patient Assistance Now Oncology (PANO) program 1 800 282 7630
Patient portal | Prescriber portal

For Reenrolling Patients: Download the NPAF application form
English (PDF 0.2 MB) | Spanish (PDF 0.2 MB)

Afinitor® (everolimus)

Income Limits
To be eligible, you must meet the income guidelines, which may vary by product and household size.
Please click on the link to see if you may qualify. Check eligibility (PDF 0.3 MB)

Application Instructions
For New Patients: Apply online through the Patient Assistance Now Oncology (PANO) program 1 800 282 7630
Patient portal | Prescriber portal

For Reenrolling Patients: Download the NPAF application form
English (PDF 0.2 MB) | Spanish (PDF 0.2 MB)

Afinitor Disperz® (everolimus suspension)

Income Limits
To be eligible, you must meet the income guidelines, which may vary by product and household size.
Please click on the link to see if you may qualify. Check eligibility (PDF 0.3 MB)

Application Instructions
For New Patients: Apply online through the Patient Assistance Now Oncology (PANO) program 1 800 282 7630
Patient portal | Prescriber portal

For Reenrolling Patients: Download the NPAF application form
English (PDF 0.2 MB) | Spanish (PDF 0.2 MB)

Beovu® (brolucizumab-dbll) Injection

Income Limits
To be eligible, you must meet the income guidelines, which may vary by product and household size.
Please click on the link to see if you may qualify. Check eligibility (PDF 0.3 MB)

Application Instructions
For New & Reenrolling Patients: Download the NPAF application form
English (PDF 0.2 MB) | Spanish (PDF 0.2 MB)

Coartem® (artemether and lumefantrine)

Income Limits
To be eligible, you must meet the income guidelines, which may vary by product and household size.
Please click on the link to see if you may qualify. Check eligibility (PDF 0.3 MB)

Application Instructions
For New & Reenrolling Patients: Download the NPAF application form
English (PDF 0.2 MB) | Spanish (PDF 0.2 MB)

Cosentyx® (secukinumab)

Income Limits
To be eligible, you must meet the income guidelines, which may vary by product and household size.
Please click on the link to see if you may qualify. Check eligibility (PDF 0.3 MB)

Application Instructions
For New & Reenrolling Patients: Download the NPAF application form
English (PDF 0.2 MB) | Spanish (PDF 0.2 MB)

Entresto™ (sacubitril/valsartan)

Income Limits
To be eligible, you must meet the income guidelines, which may vary by product and household size.
Please click on the link to see if you may qualify. Check eligibility (PDF 0.3 MB)

Application Instructions
For New & Reenrolling Patients: Download the NPAF application form
English (PDF 0.2 MB) | Spanish (PDF 0.2 MB)

Fabhalta® (iptacopan)

Income Limits
To be eligible, you must meet the income guidelines, which may vary by product and household size.
Please click on the link to see if you may qualify. View eligibility (PDF 0.2 MB)

Application Instructions
For New Patients: Apply through Novartis Patient Support at 1 833 993 2242 or visit the website at www.Fabhalta.com. Prescribers need to complete the Fabhalta Start Form found on www.fabhalta-hcp.com and send the form to Novartis Patient Support, fax number: 1 877 443 2242.

Gilenya® (fingolimod)

Income Limits
To be eligible, you must meet the income guidelines, which may vary by product and household size.
Please click on the link to see if you may qualify. Check eligibility (PDF 0.3 MB)

Application Instructions
For New & Reenrolling Patients: Download the NPAF application form
English (PDF 0.2 MB) | Spanish (PDF 0.2 MB)

Ilaris® (canakinumab)

Income Limits
To be eligible, you must meet the income guidelines, which may vary by product and household size.
Please click on the link to see if you may qualify. Check eligibility (PDF 0.3 MB)

Application Instructions
For New & Reenrolling Patients: Download the NPAF application form
English (PDF 0.2 MB) | Spanish (PDF 0.2 MB)

Jadenu ® (deferasirox)

Income Limits
To be eligible, you must meet the income guidelines, which may vary by product and household size.
Please click on the link to see if you may qualify. Check eligibility (PDF 0.3 MB)

Application Instructions
For New Patients: Apply online through the Patient Assistance Now Oncology (PANO) program 1 800 282 7630
Patient portal | Prescriber portal

For Reenrolling Patients: Download the NPAF application form
English (PDF 0.2 MB) | Spanish (PDF 0.2 MB)

Jadenu® Sprinkle (deferasirox) granules

Income Limits
To be eligible, you must meet the income guidelines, which may vary by product and household size.
Please click on the link to see if you may qualify. Check eligibility (PDF 0.3 MB)

Application Instructions
For New Patients: Apply online through the Patient Assistance Now Oncology (PANO) program 1 800 282 7630
Patient portal | Prescriber portal

For Reenrolling Patients: Download the NPAF application form
English (PDF 0.2 MB) | Spanish (PDF 0.2 MB)

Kesimpta® (ofatumumab)

Income Limits
To be eligible, you must meet the income guidelines, which may vary by product and household size.
Please click on the link to see if you may qualify. Check eligibility (PDF 0.3 MB)

Application Instructions
For New Patients: Apply through the Alongside TM KESIMPTA at 1 855 537 4678 or visit the website at www.Kesimpta.com

For Reenrolling Patients: Download the NPAF application form
English (PDF 0.2 MB) | Spanish (PDF 0.2 MB)

Kisqali® (ribociclib)

Income Limits
To be eligible, you must meet the income guidelines, which may vary by product and household size.
Please click on the link to see if you may qualify. Check eligibility (PDF 0.3 MB)

Application Instructions
For New Patients: Apply through Novartis Patient Support at 1 866 433 8000 or visit the website at www.kisqali.com. Prescribers need to complete the Kisqali Start Form found on www.kisqali-hcp.com and send the form to Novartis Patient Support, fax number: 1 800 414 3518.

For Reenrolling Patients: Download the NPAF application form
English (PDF 0.2 MB) | Spanish (PDF 0.2 MB)

Income Limits
To be eligible, you must meet the income guidelines, which may vary by product and household size.
Please click on the link to see if you may qualify. Check eligibility (PDF 0.3 MB)

Application Instructions
For New Patients: Apply through the Leqvio ® Service Center at 1 833-LEQVIO2 (833 537 8462) or visit the website at www.Leqvio.com. Prescribers need to complete the Leqvio Service Center Start Form and follow submission instructions found at www.Leqviohcp.com.

For Reenrolling Patients: Download the NPAF application form
English (PDF 0.2 MB) | Spanish (PDF 0.2 MB)

Lutathera® (lutetium Lu 177 dotatate)

Income Limits
To be eligible, you must meet the income guidelines, which may vary by product and household size.
Please click on the link to see if you may qualify. Check eligibility (PDF 0.3 MB)

Application Instructions
For New & Reenrolling Patients: Apply through RLT Novartis Patient Support 1 844 638 7222.
Prescribers use Program Enrollment Form: Novartis-PatientSupport.com/RLT

Income Limits
To be eligible, you must meet the income guidelines, which may vary by product and household size.
Please click on the link to see if you may qualify. Check eligibility (PDF 0.3 MB)

Application Instructions
For New Patients: Apply through the Mayzent ® patient support program at 1 877 629 9368 or visit the website at www.Mayzent.com.

For Reenrolling Patients: Download the NPAF application form
English (PDF 0.2 MB) | Spanish (PDF 0.2 MB)

Mekinist® (trametinib)

Income Limits
To be eligible, you must meet the income guidelines, which may vary by product and household size.
Please click on the link to see if you may qualify. Check eligibility (PDF 0.3 MB)

Application Instructions
For New Patients: Apply online through the Patient Assistance Now Oncology (PANO) program 1 800 282 7630
Patient portal | Prescriber portal

For Reenrolling Patients: Download the NPAF application form
English (PDF 0.2 MB) | Spanish (PDF 0.2 MB)

Piqray® (alpelisib)

Income Limits
To be eligible, you must meet the income guidelines, which may vary by product and household size.
Please click on the link to see if you may qualify. Check eligibility (PDF 0.3 MB)

Application Instructions
For New Patients: Apply online through the Patient Assistance Now Oncology (PANO) program 1 800 282 7630
Patient portal | Prescriber portal

For Reenrolling Patients: Download the NPAF application form
English (PDF 0.2 MB) | Spanish (PDF 0.2 MB)

Pluvicto® (177Lu-PSMA-617)

Income Limits
To be eligible, you must meet the income guidelines, which may vary by product and household size.
Please click on the link to see if you may qualify. Check eligibility (PDF 0.3 MB)

Application Instructions
For New & Reenrolling Patients: Apply through RLT Novartis Patient Support 1 844 638 7222.
Prescribers use Program Enrollment Form: Novartis-PatientSupport.com/RLT

Promacta® (eltrombopag)

Income Limits
To be eligible, you must meet the income guidelines, which may vary by product and household size.
Please click on the link to see if you may qualify. Check eligibility (PDF 0.3 MB)

Application Instructions
For New Patients: Apply online through the Patient Assistance Now Oncology (PANO) program 1 800 282 7630
Patient portal | Prescriber portal

For Reenrolling Patients: Download the NPAF application form
English (PDF 0.2 MB) | Spanish (PDF 0.2 MB)

RYDAPT® (midostaurin)

Income Limits
To be eligible, you must meet the income guidelines, which may vary by product and household size.
Please click on the link to see if you may qualify. Check eligibility (PDF 0.3 MB)

Application Instructions
For New Patients: Apply online through the Patient Assistance Now Oncology (PANO) program 1 800 282 7630
Patient portal | Prescriber portal

For Reenrolling Patients: Download the NPAF application form
English (PDF 0.2 MB) | Spanish (PDF 0.2 MB)

SANDOSTATIN LAR® DEPOT (octreotide acetate)

Income Limits
To be eligible, you must meet the income guidelines, which may vary by product and household size.
Please click on the link to see if you may qualify. Check eligibility (PDF 0.3 MB)

Application Instructions
For New Patients: Apply online through the Patient Assistance Now Oncology (PANO) program 1 800 282 7630
Patient portal | Prescriber portal

For Reenrolling Patients: Download the NPAF application form
English (PDF 0.2 MB) | Spanish (PDF 0.2 MB)

Scemblix® (asciminib) Tablets

Income Limits
To be eligible, you must meet the income guidelines, which may vary by product and household size.
Please click on the link to see if you may qualify. Check eligibility (PDF 0.3 MB)

Application Instructions
For New Patients: Apply through Novartis Patient Support at 1 866 433 8000 or visit the website at www.scemblix.com. Prescribers need to complete Scemblix Start Form found on www.scemblix-hcp.com and send the form to Novartis Patient Support, fax number: 1 800 368 5564.

For Reenrolling Patients: Download the NPAF application form
English (PDF 0.2 MB) | Spanish (PDF 0.2 MB)

Tabrecta™ (capmatinib)

Income Limits
To be eligible, you must meet the income guidelines, which may vary by product and household size.
Please click on the link to see if you may qualify. Check eligibility (PDF 0.3 MB)

Application Instructions
For New Patients: Apply online through the Patient Assistance Now Oncology (PANO) program 1 800 282 7630
Patient portal | Prescriber portal

For Reenrolling Patients: Download the NPAF application form
English (PDF 0.2 MB) | Spanish (PDF 0.2 MB)

Tafinlar® (dabrafenib)

Income Limits
To be eligible, you must meet the income guidelines, which may vary by product and household size.
Please click on the link to see if you may qualify. Check eligibility (PDF 0.3 MB)

Application Instructions
For New Patients: Apply online through the Patient Assistance Now Oncology (PANO) program 1 800 282 7630
Patient portal | Prescriber portal

For Reenrolling Patients: Download the NPAF application form
English (PDF 0.2 MB) | Spanish (PDF 0.2 MB)

Tasigna® (nilotinib)

Income Limits
To be eligible, you must meet the income guidelines, which may vary by product and household size.
Please click on the link to see if you may qualify. Check eligibility (PDF 0.3 MB)

Application Instructions
For New Patients: Apply online through the Patient Assistance Now Oncology (PANO) program 1 800 282 7630
Patient portal | Prescriber portal

For Reenrolling Patients: Download the NPAF application form
English (PDF 0.2 MB) | Spanish (PDF 0.2 MB)

Tykerb® (lapatinib)

Income Limits
To be eligible, you must meet the income guidelines, which may vary by product and household size.
Please click on the link to see if you may qualify. Check eligibility (PDF 0.3 MB)

Application Instructions
For New Patients: Apply online through the Patient Assistance Now Oncology (PANO) program 1 800 282 7630
Patient portal | Prescriber portal

For Reenrolling Patients: Download the NPAF application form
English (PDF 0.2 MB) | Spanish (PDF 0.2 MB)

Vijoice® (alpelisib)

Income Limits
To be eligible, you must meet the income guidelines, which may vary by product and household size.
Please click on the link to see if you may qualify. Check eligibility (PDF 0.3 MB)

Application Instructions
For New Patients: Apply online through the Patient Assistance Now Oncology (PANO) program 1 800 282 7630
Patient portal | Prescriber portal

For Reenrolling Patients: Download the NPAF application form
English (PDF 0.2 MB) | Spanish (PDF 0.2 MB)

Votrient® (pazopanib)

Income Limits
To be eligible, you must meet the income guidelines, which may vary by product and household size.
Please click on the link to see if you may qualify. Check eligibility (PDF 0.3 MB)

Application Instructions
For New Patients: Apply online through the Patient Assistance Now Oncology (PANO) program 1 800 282 7630
Patient portal | Prescriber portal

For Reenrolling Patients: Download the NPAF application form
English (PDF 0.2 MB) | Spanish (PDF 0.2 MB)

ZYKADIA® (ceritinib)

Income Limits
To be eligible, you must meet the income guidelines, which may vary by product and household size.
Please click on the link to see if you may qualify. Check eligibility (PDF 0.3 MB)

Application Instructions
For New Patients: Apply online through the Patient Assistance Now Oncology (PANO) program 1 800 282 7630
Patient portal | Prescriber portal

For Reenrolling Patients: Download the NPAF application form
English (PDF 0.2 MB) | Spanish (PDF 0.2 MB)